Breast Cancer, Version 3.2020, NCCN Clinical Practice Guidelines in Oncology.

Breast Neoplasms / diagnosis Clinical Decision-Making Disease Management Disease Susceptibility Female Humans Neoplasm Metastasis Neoplasm Staging Recurrence

Journal

Journal of the National Comprehensive Cancer Network : JNCCN
ISSN: 1540-1413
Titre abrégé: J Natl Compr Canc Netw
Pays: United States
ID NLM: 101162515

Informations de publication

Date de publication:
04 2020
Historique:
entrez: 8 4 2020
pubmed: 8 4 2020
medline: 17 6 2021
Statut: ppublish

Résumé

Several new systemic therapy options have become available for patients with metastatic breast cancer, which have led to improvements in survival. In addition to patient and clinical factors, the treatment selection primarily depends on the tumor biology (hormone-receptor status and HER2-status). The NCCN Guidelines specific to the workup and treatment of patients with recurrent/stage IV breast cancer are discussed in this article.

Identifiants

DOI: 10.6004/jnccn.2020.0016 PMID: 32259783
pubmed: 32259783
doi: 10.6004/jnccn.2020.0016
pii: jnccnGLS1804
doi:
pii:

Types de publication

Journal Article Practice Guideline

Langues

eng

Sous-ensembles de citation

IM

Pagination

452-478

Auteurs

William J Gradishar (WJ)

Robert H. Lurie Comprehensive Cancer Center of Northwestern University.

Benjamin O Anderson (BO)

Fred Hutchinson Cancer Research Center/Seattle Cancer Care Alliance.

Jame Abraham (J)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

Rebecca Aft (R)

Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine.

Doreen Agnese (D)

The Ohio State University Comprehensive Cancer Center - James Cancer Hospital and Solove Research Institute.

Kimberly H Allison (KH)

Stanford Cancer Institute.

Sarah L Blair (SL)

UC San Diego Moores Cancer Center.

Harold J Burstein (HJ)

Dana-Farber/Brigham and Women's Cancer Center.

Chau Dang (C)

Memorial Sloan Kettering Cancer Center.

Anthony D Elias (AD)

University of Colorado Cancer Center.

Sharon H Giordano (SH)

The University of Texas MD Anderson Cancer Center.

Matthew P Goetz (MP)

Mayo Clinic Cancer Center.

Lori J Goldstein (LJ)

Fox Chase Cancer Center.

Steven J Isakoff (SJ)

Massachusetts General Hospital Cancer Center.

Jairam Krishnamurthy (J)

Fred & Pamela Buffet Cancer Center.

Janice Lyons (J)

Case Comprehensive Cancer Center/University Hospitals Seidman Cancer Center and Cleveland Clinic Taussig Cancer Institute.

P Kelly Marcom (PK)

Duke Cancer Institute.

Jennifer Matro (J)

Abramson Cancer Center at the University of Pennsylvania.

Ingrid A Mayer (IA)

Vanderbilt-Ingram Cancer Center.

Meena S Moran (MS)

Yale Cancer Center/Smilow Cancer Hospital.

Joanne Mortimer (J)

City of Hope National Medical Center.

Ruth M O'Regan (RM)

University of Wisconsin Carbone Cancer Center.

Sameer A Patel (SA)

Fox Chase Cancer Center.

Lori J Pierce (LJ)

University of Michigan Rogel Cancer Center.

Hope S Rugo (HS)

UCSF Helen Diller Family Comprehensive Cancer Center.

Amy Sitapati (A)

UC San Diego Moores Cancer Center.

Karen Lisa Smith (KL)

The Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins.

Mary Lou Smith (ML)

Research Advocacy Network.

Hatem Soliman (H)

Moffitt Cancer Center.

Erica M Stringer-Reasor (EM)

O'Neal Comprehensive Cancer Center at UAB.

Melinda L Telli (ML)

Stanford Cancer Institute.

John H Ward (JH)

Huntsman Cancer Institute at the University of Utah.

Jessica S Young (JS)

Roswell Park Comprehensive Cancer Center; and.

Jennifer L Burns (JL)

National Comprehensive Cancer Network.

Rashmi Kumar (R)

National Comprehensive Cancer Network.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du sein › Tumeurs du sein › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › Diagnostic › Prise de décision clinique › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › Administration des services de santé › Gestion des soins aux patients › Prise en charge de la maladie › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › Phénomènes physiologiques › Constitution physique › Prédisposition aux maladies › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Processus néoplasiques › Métastase tumorale › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › Diagnostic › Pronostic › Stadification tumorale › Breast Cancer, Version 3.2020, NCCN Clinical...
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Caractéristiques de la maladie › Récidive › Breast Cancer, Version 3.2020, NCCN Clinical...